Formalin and 2.5% Glutaraldehyde/2% Paraformaldehyde in 0.1 M Cacodylate Buffer Inactivation Protocols to Ensure the Proper Fixation of Positive Sense RNA Viruses and Genomic Material Prior to Removal from Containment.

Autor: Panny LE; Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA., Piper AE; Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA., Gardner CL; Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA., Burke CW; Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA.

Publikováno v: Methods and protocols [Methods Protoc] 2024 Dec 21; Vol. 7 (6). Date of Electronic Publication: 2024 Dec 21.

Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses.

Autor: Milligan JC; Center for Infectious Disease and Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA., Davis CW; Emory Vaccine Center and Department of Microbiology and Immunology, Emory University, Atlanta, GA 30322, USA., Yu X; Center for Infectious Disease and Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Ilinykh PA; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA; Galveston National Laboratory, Galveston, TX, 77550, USA., Huang K; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA; Galveston National Laboratory, Galveston, TX, 77550, USA., Halfmann PJ; Division of Pathobiological Sciences, University of Wisconsin, Madison, WI 53706, USA., Cross RW; Galveston National Laboratory, Galveston, TX, 77550, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Borisevich V; Galveston National Laboratory, Galveston, TX, 77550, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Agans KN; Galveston National Laboratory, Galveston, TX, 77550, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Geisbert JB; Galveston National Laboratory, Galveston, TX, 77550, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Chennareddy C; Emory Vaccine Center and Department of Microbiology and Immunology, Emory University, Atlanta, GA 30322, USA., Goff AJ; Virology Division, United States Army Research Institute for Infectious Disease, Fort Detrick, Frederick, MD 21702, USA., Piper AE; Virology Division, United States Army Research Institute for Infectious Disease, Fort Detrick, Frederick, MD 21702, USA., Hui S; Center for Infectious Disease and Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA., Shaffer KCL; Center for Infectious Disease and Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA., Buck T; Center for Infectious Disease and Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA., Heinrich ML; Zalgen Labs, Germantown, MD 20876, USA., Branco LM; Zalgen Labs, Germantown, MD 20876, USA., Crozier I; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Holbrook MR; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA., Kuhn JH; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA., Kawaoka Y; Division of Pathobiological Sciences, University of Wisconsin, Madison, WI 53706, USA; Department of Microbiology and Immunology, Division of Virology, Institute of Medical Science, Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Glass PJ; Virology Division, United States Army Research Institute for Infectious Disease, Fort Detrick, Frederick, MD 21702, USA., Bukreyev A; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA; Galveston National Laboratory, Galveston, TX, 77550, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Geisbert TW; Galveston National Laboratory, Galveston, TX, 77550, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Worwa G; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA. Electronic address: gabriella.worwa@nih.gov., Ahmed R; Emory Vaccine Center and Department of Microbiology and Immunology, Emory University, Atlanta, GA 30322, USA. Electronic address: rahmed@emory.edu., Saphire EO; Center for Infectious Disease and Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: erica@lji.org.

Publikováno v: Cell [Cell] 2022 Mar 17; Vol. 185 (6), pp. 995-1007.e18.

Modeling the stability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on skin, currency, and clothing.

Autor: Harbourt DE; Biosafety Division, United States Army Medical Research Institute of Infectious Diseases, Ft. Detrick Maryland, United States of America., Haddow AD; General Dynamics Health Solutions in support of USAMRIID, Ft. Detrick, Maryland, United States of America., Piper AE; Oak Ridge Institute of Science and Education, Ft. Detrick, Maryland, United States of America., Bloomfield H; Core Laboratory Services Directorate, United States Army Medical Research Institute of Infectious Diseases, Ft. Detrick Maryland, United States of America., Kearney BJ; Core Laboratory Services Directorate, United States Army Medical Research Institute of Infectious Diseases, Ft. Detrick Maryland, United States of America., Fetterer D; ICON Global Public Health Solutions, Ft. Detrick, Maryland, United States of America., Gibson K; Core Laboratory Services Directorate, United States Army Medical Research Institute of Infectious Diseases, Ft. Detrick Maryland, United States of America., Minogue T; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases, Ft. Detrick Maryland, United States of America.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Nov 09; Vol. 14 (11), pp. e0008831. Date of Electronic Publication: 2020 Nov 09 (Print Publication: 2020).

A small molecule inhibitor of MyD88 exhibits broad spectrum antiviral activity by up regulation of type I interferon.

Autor: Saikh KU; Department of Bacterial Immunology, Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Frederick, MD, 21702, USA. Electronic address: kamal.u.saikh.civ@mail.mil., Morazzani EM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Frederick, MD, 21702, USA., Piper AE; Virology Division, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Frederick, MD, 21702, USA., Bakken RR; Virology Division, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Frederick, MD, 21702, USA., Glass PJ; Virology Division, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Frederick, MD, 21702, USA.

Publikováno v: Antiviral research [Antiviral Res] 2020 Sep; Vol. 181, pp. 104854. Date of Electronic Publication: 2020 Jul 02.

Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection.

Autor: Davis CW; Emory Vaccine Center and Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA., Jackson KJL; Department of Pathology, Stanford University, Stanford, CA, USA; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia., McElroy AK; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Pediatric Infectious Disease, Emory University, Atlanta, GA, USA; Division of Pediatric Infectious Disease, University of Pittsburgh, Pittsburgh, PA, USA., Halfmann P; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, WI, USA., Huang J; Emory Vaccine Center and Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA., Chennareddy C; Emory Vaccine Center and Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA., Piper AE; Virology Division, United States Army Medical Research Institute for Infectious Diseases, Fort Detrick, MD, USA., Leung Y; Atreca, Redwood City, CA, USA., Albariño CG; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Crozier I; Integrated Research Facility at Fort Detrick, Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institutes, Frederick, MD, USA., Ellebedy AH; Emory Vaccine Center and Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA; Division of Immunobiology, Department of Pathology and Immunology Washington University School of Medicine, St. Louis, MO, USA., Sidney J; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA., Sette A; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Department of Medicine, University of California San Diego, La Jolla, CA, USA., Yu T; Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA., Nielsen SCA; Department of Pathology, Stanford University, Stanford, CA, USA., Goff AJ; Virology Division, United States Army Medical Research Institute for Infectious Diseases, Fort Detrick, MD, USA., Spiropoulou CF; Viral Special Pathogens Branch, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Saphire EO; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA; La Jolla Institute for Immunology, La Jolla, CA, USA., Cavet G; Atreca, Redwood City, CA, USA., Kawaoka Y; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, WI, USA; Division of Virology, Department of Microbiology and Immunology, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Mehta AK; Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, GA, USA., Glass PJ; Virology Division, United States Army Medical Research Institute for Infectious Diseases, Fort Detrick, MD, USA., Boyd SD; Department of Pathology, Stanford University, Stanford, CA, USA., Ahmed R; Emory Vaccine Center and Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA. Electronic address: rahmed@emory.edu.

Publikováno v: Cell [Cell] 2019 May 30; Vol. 177 (6), pp. 1566-1582.e17. Date of Electronic Publication: 2019 May 16.